Androgel and Edurant drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Androgel (testosterone) and Edurant (rilpivirine hydrochloride). Common drug interactions include emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Androgel and Edurant. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Androgel?

Androgel has active ingredients of testosterone. It is often used in testosterone. eHealthMe is studying from 25,763 Androgel users. Check the latest studies of Androgel.

What is Edurant?

Edurant has active ingredients of rilpivirine hydrochloride. eHealthMe is studying from 2,238 Edurant users. Check the latest studies of Edurant.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 25, 2026

14 people who take Androgel and Edurant together, and have interactions are studied.

Androgel and Edurant drug interactions.

What are the common drug interactions of Androgel and Edurant, by gender? *:

female:

n/a

male:

  1. Emotional distress
  2. Pain
  3. Tooth loss
  4. Femoral neck fracture (neck of femur bone fracture)
  5. Multiple fractures
  6. Osteomalacia (softening of the bones due to a lack of vitamin d)
  7. Osteoporotic fracture (fracture due to weak bone)
  8. Back pain
  9. Blood creatinine increased
  10. Insomnia (sleeplessness)

What are the common drug interactions of Androgel and Edurant, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Back pain
  5. Blood creatinine increased
  6. Depression
  7. Emotional distress
  8. Insomnia (sleeplessness)
  9. Nocturia (the need to get up in the night to urinate)
  10. Pain

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Renal failure (kidney dysfunction)
  6. Blood triglycerides increased
  7. Osteonecrosis (death of bone)
  8. Osteopenia (a condition where bone mineral density is lower than normal)
  9. Osteoporosis (bones weak and more likely to break)
  10. Back pain

50-59:

  1. Osteoporosis (bones weak and more likely to break)
  2. Bone density decreased
  3. Emotional distress
  4. Pain
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Anxiety
  8. Chronic kidney disease
  9. Depression
  10. Multiple fractures

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Tooth loss
  4. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Bone density decreased
  8. Emotional distress
  9. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  10. Nephrogenic anaemia (anaemia due to kidney disease)

What are the existing conditions these people have? *

  1. Hiv Infection: 14 people, 100.00%
  2. Peripheral Swelling: 2 people, 14.29%
  3. Depression: 2 people, 14.29%
  4. Rickets (softening of bones): 1 person, 7.14%
  5. Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 1 person, 7.14%
  6. Nausea (feeling of having an urge to vomit): 1 person, 7.14%
  7. Infection: 1 person, 7.14%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 7.14%
  9. Hypersensitivity: 1 person, 7.14%
  10. High Blood Pressure: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Androgel and Edurant?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Androgel and Edurant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Androgel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Edurant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Androgel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Edurant and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on testosterone and rilpivirine hydrochloride (the active ingredients of Androgel and Edurant, respectively), and Androgel and Edurant (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: